Welcure Drugs And Pharmaceuticals Limited
About Welcure Drugs And Pharmaceuticals Limited
Data last updated: 14 July 2026
Welcure Drugs And Pharmaceuticals Limited is a public limited company based in New Delhi, Delhi, India. It specialises in industrial machinery manufacturing, a part of the broader machinery and industrial equipment sector. Incorporated on 06 August 1996, the company has been in operation for over 30 years.
Registered with ROC Delhi under CIN L68100DL1996PLC227773. Listed on BSE: 524661.
Capital: an authorised share capital of ₹116 Cr and a paid-up capital of ₹112.44 Cr. It is led by directors including Bhumika Pradhan and Ravi Thakor.
Last AGM: 27 September 2025. Financial statements filed for year ended 31 March 2025. Office: Plot No. 55 Office No. 104 First Floor Vijay Block, Laxmi Nagar East Delhi, New Delhi, Delhi, India – 110092.
As per BSE-filed standalone financials for FY 2026, the company reported a revenue of ₹365.54 Cr, reflecting significant growth compared to the previous year. The net worth stands at ₹97.02 Cr (down 5.36% YoY). Total assets are valued at ₹510.19 Cr (up 91.1% YoY).
As per MCA filings, the company has satisfied charges of ₹22.08 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social MediaLocked
-
Registered AddressPlot No. 55 Office No. 104 First Floor Vijay Block, Laxmi Nagar East Delhi, New Delhi, Delhi, India – 110092
-
IndustryMachinery and Equipment, Industrial Machinery Manufacturing
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
CIN History of Welcure Drugs And Pharmaceuticals Limited
Welcure Drugs And Pharmaceuticals Limited has 2 previous CINs, indicating changes in the company's corporate structure or registration details. The current CIN is L68100DL1996PLC227773, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| L68100DL1996PLC227773 | Current |
| L24232DL1996PLC227773 | Previous |
| L24232RJ1996PLC012418 | Previous |
Auditor Details of Welcure Drugs And Pharmaceuticals Limited
Welcure Drugs And Pharmaceuticals Limited is audited by SARANG SHIVAJIRAO CHAVAN AND ASSOCIATES (ICAI peer reviewed, certificate valid till 2028-06-30) for the financial year 2026, as reported in its BSE exchange filings. The statutory auditor is responsible for expressing an independent opinion on whether the financial statements present a true and fair view in accordance with applicable accounting standards.
| Name | Financial year | Audit opinion |
|---|---|---|
| SARANG SHIVAJIRAO CHAVAN AND ASSOCIATES (ICAI peer reviewed, certificate valid till 2028-06-30) | FY 2026 | Declaration of unmodified opinion |
Board of Directors and KMP of Welcure Drugs And Pharmaceuticals Limited
Welcure Drugs And Pharmaceuticals Limited currently reports 3 directors and 1 key managerial person. 32 former directors have served the organization.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
|
Bhumika Pradhan
Also directs:
Welcure Drugs And Pharmaceuticals Limited
|
Director | 05 Aug 2025 | 0 Years 11 Months | Current |
|
Ravi Thakor
Also directs:
Welcure Drugs And Pharmaceuticals Limited
|
Director | 05 Aug 2025 | 0 Years 11 Months | Current |
|
Yogeshkumar Prajapati
Also directs:
Welcure Drugs And Pharmaceuticals Limited
|
Director | 05 Aug 2025 | 0 Years 11 Months | Current |
|
Chintan Didawala
Also directs:
Welcure Drugs And Pharmaceuticals Limited
|
Cfo | 06 May 2025 | 1 Years 2 Months | Current |
Financials of Welcure Drugs And Pharmaceuticals Limited FY 2026 filings available
Welcure Drugs And Pharmaceuticals Limited reported revenue of ₹365.54 Cr (up 1388.95% YoY) for FY 2026.
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹365.54 Cr | ₹24.55 Cr | ₹0 | ₹0 | ₹10.5 Lakh | ₹13.33 Lakh | ₹8.25 Lakh | ₹7.95 Lakh |
| Other Income | ₹1.46 Cr | ₹1.91 Cr | ₹9.4 Lakh | ₹23.71 Lakh | ₹0 | ₹2,000 | ₹3,000 | ₹16,000 |
| Total Income | ₹367 Cr | ₹26.46 Cr | ₹9.4 Lakh | ₹23.71 Lakh | ₹10.5 Lakh | ₹13.35 Lakh | ₹8.28 Lakh | ₹8.11 Lakh |
| Cost of Materials Consumed | ₹322.37 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹164.03 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Changes in Inventories | ₹0 | -₹143.52 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Employee Benefit Expense | ₹10.36 Lakh | ₹27.65 Lakh | ₹8.8 Lakh | ₹4.01 Lakh | ₹1.29 Lakh | ₹84,000 | ₹84,000 | ₹42,000 |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹1.91 Lakh | ₹76,000 | ₹3.6 Lakh | ₹32,000 | ₹0 | ₹0 | ₹0 | ₹0 |
| Other Expenses | ₹50 Cr | ₹2.89 Cr | ₹14.5 Lakh | ₹9.21 Lakh | ₹6.85 Lakh | ₹7 Lakh | ₹8.39 Lakh | ₹7.3 Lakh |
| Total Expenses | ₹372.49 Cr | ₹23.68 Cr | ₹26.9 Lakh | ₹13.54 Lakh | ₹8.14 Lakh | ₹7.84 Lakh | ₹9.23 Lakh | ₹7.72 Lakh |
| Profit Before Exceptional Items & Tax | -₹5.49 Cr | ₹2.78 Cr | -₹17.5 Lakh | ₹10.17 Lakh | ₹2.36 Lakh | ₹5.51 Lakh | -₹95,000 | ₹39,000 |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Profit Before Tax | -₹5.49 Cr | ₹2.78 Cr | -₹17.5 Lakh | ₹10.17 Lakh | ₹2.36 Lakh | ₹5.51 Lakh | -₹95,000 | ₹39,000 |
| Total Tax Expense | ₹0 | ₹61 Lakh | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Profit | -₹5.49 Cr | ₹2.17 Cr | -₹17.5 Lakh | ₹10.17 Lakh | ₹2.36 Lakh | ₹5.51 Lakh | -₹95,000 | ₹39,000 |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Comprehensive Income | -₹5.49 Cr | ₹2.17 Cr | -₹17.5 Lakh | ₹10.17 Lakh | ₹2.36 Lakh | ₹5.51 Lakh | -₹95,000 | ₹39,000 |
| EBITDA (computed) | -₹5.47 Cr | ₹2.79 Cr | -₹13.9 Lakh | ₹10.49 Lakh | ₹2.36 Lakh | ₹5.51 Lakh | -₹95,000 | ₹39,000 |
| Basic EPS | ₹-0.04 | ₹0.36 | ₹-0.13 | ₹0.00 | ₹0.02 | ₹0.05 | ₹-0.01 | ₹0.00 |
| Diluted EPS | ₹-0.04 | ₹0.36 | ₹-0.13 | ₹0.00 | ₹0.02 | ₹0.05 | ₹-0.01 | ₹0.00 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹510.19 Cr | ₹266.98 Cr | ₹1.37 Cr | ₹1.53 Cr | ₹9.68 Lakh | ₹7.3 Lakh | ₹2.46 Lakh | ₹2.98 Lakh |
| Non-current Assets | ₹152.64 Cr | ₹84.84 Cr | ₹1.34 Cr | ₹1.52 Cr | ₹3.08 Lakh | ₹0 | ₹0 | ₹0 |
| Current Assets | ₹357.55 Cr | ₹182.14 Cr | ₹3.18 Lakh | ₹59,000 | ₹6.6 Lakh | ₹7.3 Lakh | ₹2.46 Lakh | ₹2.98 Lakh |
| Property, Plant & Equipment | ₹1.11 Lakh | ₹3.03 Lakh | ₹2.09 Lakh | ₹5.68 Lakh | ₹0 | ₹0 | ₹0 | ₹0 |
| Inventories | ₹143.52 Cr | ₹143.52 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Trade Receivables | ₹213.36 Cr | ₹18.95 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Cash & Equivalents | ₹57.62 Lakh | ₹12.83 Lakh | ₹2.16 Lakh | ₹0 | ₹6.6 Lakh | ₹4.75 Lakh | ₹53,000 | ₹1.5 Lakh |
| Equity (Net Worth) | ₹97.02 Cr | ₹102.51 Cr | ₹1.34 Cr | ₹1.52 Cr | ₹9.3 Lakh | ₹6.94 Lakh | ₹1.43 Lakh | ₹2.37 Lakh |
| Equity Share Capital | ₹123.59 Cr | ₹112.44 Cr | ₹13.44 Cr | ₹13.44 Cr | ₹12.12 Cr | ₹12.12 Cr | ₹12.12 Cr | ₹12.12 Cr |
| Borrowings (Non-current) | ₹0 | ₹123.2 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Borrowings (Current) | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Total Debt (computed) | ₹0 | ₹123.2 Cr | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Current Liabilities | ₹213.7 Cr | ₹41.27 Cr | ₹3.06 Lakh | ₹1.36 Lakh | ₹38,000 | ₹36,000 | ₹1.03 Lakh | ₹61,000 |
| Total Liabilities | ₹413.17 Cr | ₹164.47 Cr | ₹3.06 Lakh | ₹1.36 Lakh | ₹38,000 | ₹36,000 | ₹1.03 Lakh | ₹61,000 |
| Metrics | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
| Operating Cash Flow | ₹1.74 Cr | -₹222.03 Cr | -₹12.76 Lakh | ₹10.69 Lakh | ₹1.85 Lakh |
| Investing Cash Flow | -₹1.29 Cr | -₹6.35 Lakh | ₹16.5 Lakh | ₹1.32 Cr | ₹0 |
| Financing Cash Flow | ₹0 | ₹222.2 Cr | -₹1.7 Lakh | -₹1.49 Cr | ₹0 |
| Capital Expenditure | ₹0 | ₹1.7 Lakh | ₹0 | ₹0 | ₹0 |
| Free Cash Flow (computed) | ₹1.74 Cr | -₹222.05 Cr | -₹12.76 Lakh | ₹10.69 Lakh | ₹1.85 Lakh |
| Dividends Paid | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Net Change in Cash | ₹44.79 Lakh | ₹10.67 Lakh | ₹2.04 Lakh | -₹6.48 Lakh | ₹1.85 Lakh |
| Metrics | Q4 FY26 | Q3 FY26 | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 | Q1 FY25 |
|---|---|---|---|---|---|---|---|---|
| Revenue from Operations | ₹0 | ₹0 | ₹65.62 Cr | ₹299.91 Cr | ₹21.21 Cr | ₹8.84 Cr | ₹24.55 Cr | ₹0 |
| Other Income | ₹0 | ₹1.46 Cr | ₹0 | ₹0 | ₹1.91 Cr | ₹0 | ₹0 | ₹0 |
| Total Income | ₹0 | ₹1.46 Cr | ₹65.62 Cr | ₹299.91 Cr | ₹23.12 Cr | ₹8.84 Cr | ₹24.55 Cr | - |
| Cost of Materials Consumed | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Purchases of Stock-in-Trade | ₹0 | ₹0 | ₹54.13 Cr | ₹268.72 Cr | ₹147.62 Cr | ₹0 | ₹164.03 Cr | ₹0 |
| Changes in Inventories | ₹0 | ₹0 | ₹0 | ₹0 | -₹129.91 Cr | ₹7.38 Cr | -₹143.52 Cr | ₹0 |
| Employee Benefit Expense | ₹0 | ₹1.94 Lakh | ₹1.36 Lakh | ₹3.23 Lakh | ₹25.01 Lakh | ₹11.45 Lakh | ₹9.7 Lakh | ₹5.3 Lakh |
| Finance Costs | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 |
| Depreciation & Amortisation | ₹0 | ₹50,000 | ₹48,000 | ₹48,000 | ₹64,000 | ₹48,000 | ₹56,000 | - |
| Other Expenses | ₹49.86 Cr | ₹1.44 Lakh | ₹11 Lakh | ₹2.25 Lakh | ₹2.61 Cr | ₹42.34 Lakh | ₹2.11 Cr | ₹29 Lakh |
| Total Expenses | ₹49.86 Cr | ₹3.88 Lakh | ₹54.26 Cr | ₹268.78 Cr | ₹20.58 Cr | ₹7.92 Cr | ₹22.71 Cr | ₹34.5 Lakh |
| Profit Before Exceptional Items & Tax | -₹49.86 Cr | ₹1.43 Cr | ₹11.36 Cr | ₹31.14 Cr | ₹2.54 Cr | ₹91.37 Lakh | ₹1.84 Cr | - |
| Exceptional Items | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - |
| Profit Before Tax | -₹49.86 Cr | ₹1.43 Cr | ₹11.36 Cr | ₹31.14 Cr | ₹2.54 Cr | ₹91.37 Lakh | ₹1.84 Cr | -₹34.5 Lakh |
| Total Tax Expense | ₹0 | ₹35.88 Lakh | ₹2.86 Cr | ₹7.84 Cr | ₹0 | ₹49.92 Lakh | ₹0 | ₹0 |
| Net Profit | -₹49.86 Cr | ₹1.07 Cr | ₹8.5 Cr | ₹23.3 Cr | ₹2.54 Cr | ₹41.45 Lakh | ₹1.84 Cr | -₹34.5 Lakh |
| Other Comprehensive Income | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | ₹0 | - |
| Total Comprehensive Income | -₹49.86 Cr | ₹1.07 Cr | ₹8.5 Cr | ₹23.3 Cr | ₹2.54 Cr | ₹41.45 Lakh | ₹1.84 Cr | - |
| EBITDA (computed) | -₹49.86 Cr | ₹1.43 Cr | ₹11.37 Cr | ₹31.14 Cr | ₹2.55 Cr | ₹91.85 Lakh | ₹1.84 Cr | - |
| Basic EPS | ₹-0.40 | ₹0.13 | ₹0.76 | ₹2.07 | ₹0.33 | ₹0.04 | ₹0.16 | - |
| Diluted EPS | ₹-0.40 | ₹0.13 | ₹0.76 | ₹2.07 | ₹0.33 | ₹0.04 | ₹0.16 | - |
| Segment · Q4 FY26 (latest quarter) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Agriculture | ₹0 | -₹49.86 Cr | ₹510.19 Cr | ₹498.94 Cr |
| Drugs and Pharmaceuticals | ₹0 | ₹0 | ₹0 | ₹0 |
| Segment · FY 2026 (annual) | Revenue | Result (PBIT) | Assets | Liabilities |
|---|---|---|---|---|
| Agriculture | ₹367 Cr | -₹5.49 Cr | - | - |
| Drugs and Pharmaceuticals | ₹0 | ₹0 | - | - |
Charges & Borrowings of Welcure Drugs And Pharmaceuticals Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 28 Sep 2004 | State Bank of India | ₹3.68 Cr | Satisfied |
| 30 Aug 2004 | State Bank of India | ₹18.4 Cr | Satisfied |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Welcure Drugs And Pharmaceuticals Limited
View historical data on people associated with Welcure Drugs And Pharmaceuticals Limited, including employment history and EPFO contributions.
Employee and EPFO history for Welcure Drugs And Pharmaceuticals Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Welcure Drugs And Pharmaceuticals Limited
GST registrations and filing compliance for Welcure Drugs And Pharmaceuticals Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Welcure Drugs And Pharmaceuticals Limited
Credit ratings, litigation, and regulatory alerts for Welcure Drugs And Pharmaceuticals Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Welcure Drugs And Pharmaceuticals Limited
MSME payment history for Welcure Drugs And Pharmaceuticals Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Welcure Drugs And Pharmaceuticals Limited
Corporate group structure for Welcure Drugs And Pharmaceuticals Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Welcure Drugs And Pharmaceuticals Limited
MCA filings and documents for Welcure Drugs And Pharmaceuticals Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Welcure Drugs And Pharmaceuticals Limited
Recent News on Welcure Drugs And Pharmaceuticals Limited
Frequently Asked Questions about Welcure Drugs And Pharmaceuticals Limited
Welcure Drugs And Pharmaceuticals Limited is an active public limited company in the machinery and equipment sector based in New Delhi, Delhi, India. It was incorporated on 06 August 1996 (30+ years old) and is registered under CIN L68100DL1996PLC227773. Listed on BSE: 524661.
Welcure Drugs And Pharmaceuticals Limited reported revenue of ₹365.54 Cr for FY 2026 (up 1388.95% YoY) based on standalone BSE filings.
The current directors and KMP of Welcure Drugs And Pharmaceuticals Limited are:
- Bhumika Pradhan - Director
- Ravi Thakor - Director
- Yogeshkumar Prajapati - Director
- Chintan Didawala - Cfo
The primary industry of Welcure Drugs And Pharmaceuticals Limited is machinery and equipment. The company specifically operates in industrial machinery manufacturing. The company is currently active in this sector.
Yes. Welcure Drugs And Pharmaceuticals Limited is listed on BSE with code 524661.
Welcure Drugs And Pharmaceuticals Limited can be reached at the registered office: Plot No. 55 Office No. 104 First Floor Vijay Block, Laxmi Nagar East Delhi, New Delhi, Delhi, India – 110092.